ABVC BioPharma ABVC

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
-$0.01 (-1.70%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Business overview of ABVC BioPharma (ABVC)
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

Key Insights

Critical company metrics and information

  • Latest Closing Price

    $0.6386

  • Market Cap

    $15.13 Million

  • Price-Earnings Ratio

    -31.93

  • Total Outstanding Shares

    12.98 Million Shares

  • Total Employees

    19

  • Dividend

    $0.04 Per Share Quarterly

  • IPO Date

    November 9, 2004

  • SIC Description

    Pharmaceutical Preparations

  • Primary Exchange

    NASDAQ

  • Type

    Common Stock

  • Headquarters

    44370 old warm springs blvd., Fremont, CA, 94538

  • Homepage

    https://www.abvcpharma.com

Historical Stock Splits

If you bought 3.712 shares of ABVC before June 9, 2005, you'd have 1 share today.
Execution DateSplit Amount
July 25, 20231-for-10 (Reverse Split)
May 8, 20191-for-18 (Reverse Split)
April 11, 20163.141-for-1
December 28, 20105-for-1
June 19, 20072.573255-for-1
June 9, 20051.2-for-1

Cash Flow Statement

July 1, 2024 to September 30, 2024
MetricValue
Net Cash Flow From Financing Activities, Continuing$-145,393
Net Cash Flow$-773
Exchange Gains/Losses$773
Net Cash Flow From Investing Activities, Continuing$-26,331
Net Cash Flow From Financing Activities$-145,393
Net Cash Flow From Investing Activities$-27,104

Income Statement

July 1, 2024 to September 30, 2024
MetricValue
Benefits Costs and Expenses$523,193
Income/Loss From Continuing Operations Before Tax$-133,917
Income Tax Expense/Benefit$355
Net Income/Loss$-134,272
Research and Development$37,825
Selling, General, and Administrative Expenses$301,208

Comprehensive Income

July 1, 2024 to September 30, 2024
MetricValue
Comprehensive Income/Loss Attributable To Parent$-161,172
Comprehensive Income/Loss$-161,172
Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
Other Comprehensive Income/Loss$-26,900

Balance Sheet

July 1, 2024 to September 30, 2024
MetricValue
Current Liabilities$6.32 Million
Wages$89,902
Noncurrent Assets$12.31 Million
Liabilities$6.48 Million
Liabilities And Equity$14.46 Million
Current Assets$2.15 Million

Historical Dividends

Current dividend: $0.04 Per Share Quarterly
Announcement DatePayment DateRecord DateAmountFrequency
Feb 26, 2013Apr 4, 2013Mar 8, 2013$0.039838Quarterly
Dec 17, 2012Jan 29, 2013Dec 31, 2012$0.396951Biannually
Dec 17, 2012Jan 29, 2013Dec 31, 2012$0.053907Quarterly
Sep 21, 2012Oct 22, 2012Oct 3, 2012$0.054374Quarterly
Sep 21, 2012Oct 22, 2012Oct 3, 2012$0.206165Biannually

Recent Headlines From The Web

Latest news, press releases, and media coverage about ABVC from trusted financial sources
    All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

    ⓒ 2025 Financhle. All Rights Reserved.